Rhizome AI
YC W26New York City, US · Founded 2025 · 1 employees · 1 known investors
Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention. The product serves pharmaceutical companies, consultants, and researchers who need to understand regulatory positions and guidance from FDA, EMA, and other regional authorities.
Founders & leadership· Y Combinator alumni (W26)
Chetan MishrainFounder
Investors · 1
In the news
- Claude's Corner: Rhizome AI — The FDA Whisperer for Biotech | StartupHub.aistartuphub.ai · 2026
- Rhizome AI - 2026 Company Profile, Team & Funding - Tracxntracxn.com · 2025
- Rhizome AI Secures $2.5M Pre-Seed Funding to Transform Chemistry with Applied AI Innovation | Signalbasetrysignalbase.com · 2025
- Rhizome AI Funding | Complete Analysis | Extruct AIextruct.ai